Funding for this research was provided by:
Natural Science Foundation of Guangdong Province (2021A030413428)
Shenzhen Fundamental Research Program (JCYJ20190808122003692)
Shenzhen Peacock Plan (RC00339)
Received: 29 December 2021
Accepted: 16 March 2022
First Online: 26 July 2022
: This study was authorized by the Institutional Review Board and Ethics Committee of Shenzhen University General Hospital. The Institutional Review Board and Ethics Committee approved the differentiation of PGCs from human pluripotent stem cells.
: Not applicable.
: The authors declare that they have no competing interests.